| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |